U.S. flag

An official website of the United States government

NM_000518.5(HBB):c.344T>C (p.Leu115Pro) AND HEMOGLOBIN DURHAM-N.C.

Germline classification:
other (1 submission)
Last evaluated:
Feb 1, 2001
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000016777.13

Allele description [Variation Report for NM_000518.5(HBB):c.344T>C (p.Leu115Pro)]

NM_000518.5(HBB):c.344T>C (p.Leu115Pro)

Genes:
LOC110006319:beta-globin gene 3' regulatory region [Gene]
HBB:hemoglobin subunit beta [Gene - OMIM - HGNC]
LOC107133510:origin of replication at HBB [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.4
Genomic location:
Preferred name:
NM_000518.5(HBB):c.344T>C (p.Leu115Pro)
Other names:
L114P
HGVS:
  • NC_000011.10:g.5225698A>G
  • NG_000007.3:g.71918T>C
  • NG_046672.1:g.3633A>G
  • NG_053049.1:g.2019A>G
  • NG_059281.1:g.6374T>C
  • NM_000518.5:c.344T>CMANE SELECT
  • NP_000509.1:p.Leu115Pro
  • LRG_1232t1:c.344T>C
  • LRG_1232:g.6374T>C
  • LRG_1232p1:p.Leu115Pro
  • NC_000011.9:g.5246928A>G
  • NM_000518.4:c.344T>C
  • P68871:p.Leu115Pro
Protein change:
L115P; LEU114PRO
Links:
UniProtKB: P68871#VAR_010145; OMIM: 141900.0424; dbSNP: rs36015961
NCBI 1000 Genomes Browser:
rs36015961
Molecular consequence:
  • NM_000518.5:c.344T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
HEMOGLOBIN DURHAM-N.C.
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000037047OMIM
no assertion criteria provided
other
(Feb 1, 2001)
germlineliterature only

PubMed (3)
[See all records that cite these PMIDs]

De Jong, W. W. W., Went, L. N., Bernini, L. F. Abnormal haemoglobin--chemical characterization of hemoglobin Leiden. Nature 220: 788-789, 1968.

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

A novel beta-globin structural mutant, Hb Brescia (beta 114 Leu-Pro), causing a severe beta-thalassemia intermedia phenotype.

Murru S, Poddie D, Sciarratta GV, Agosti S, Baffico M, Melevendi C, Pirastu M, Cao A.

Hum Mutat. 1992;1(2):124-8.

PubMed [citation]
PMID:
1301199

Hb D-Granada or alpha 2 beta 2 22(B4)Glu----Val.

de Pablos JM, Kutlar A, Wilson JB, Webber BB, Hu H, Huisman TH.

Hemoglobin. 1987;11(6):563-5. No abstract available.

PubMed [citation]
PMID:
3446652
See all PubMed Citations (3)

Details of each submission

From OMIM, SCV000037047.12

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (3)

Description

In a family of northern Italian descent (Brescia-Lombardia), Murru et al. (1992) found that a 14-year-old girl with the clinical phenotype of severe thalassemia intermedia (613985) had a heterozygous CTG-to-CCG change at codon 114 resulting in substitution of proline for leucine in the beta-globin chain. The resulting hemoglobin tetramer was highly unstable and precipitated to form inclusion bodies in peripheral red blood cells. The unusually severe phenotype present in this heterozygote was thought to be explained by the coinheritance of a triple alpha-globin locus.

In a 29-year-old female of Irish descent with thalassemia-like anemia during her first pregnancy, deCastro et al. (1992) found no gross structural alteration on Southern blot analysis of the globin genes but found an alpha:beta globin chain synthesis ratio of 0.91 (control = 0.94). Because they suspected an unstable hemoglobinopathy and because many of these disorders are due to point mutations in exon 3 of the beta-globin chain, they performed PCR-SSCP analysis, which showed an abnormality. Sequencing demonstrated a T-to-C transition at codon 114 resulting in a leucine-to-proline substitution. They called the hemoglobin variant Durham-N.C. to distinguish it from hemoglobin Durham, named for the city in England. The mutation created a novel MspI restriction site in exon 3 of the HBB gene. De Castro et al. (1994) demonstrated that this hemoglobinopathy, like several others within exon 3 of the beta-globin gene, e.g., Hb Showa-Yakushiji (leu110-to-pro; 141900.0262), result in a thalassemic and/or hemolytic phenotype with moderately severe microcytic anemia inherited as an autosomal dominant.

Kim et al. (2001) described the molecular and hematologic characteristics of a Korean family with a dominantly inherited beta-thalassemia. Carriers were characterized by moderate anemia, hypochromia, microcytosis, elevated Hb A2 and Hb F levels, and splenomegaly. A CTG (leu) to CCG (pro) change at codon 114 of the HBB was demonstrated. They referred to the abnormal hemoglobin as Hb Durham-N.C./Brescia.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 9, 2024